Protalix BioTherapeutics
PLX
#8648
Rank
C$0.10 B
Marketcap
$1.49
Share price
-4.35%
Change (1 day)
-35.23%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : C$61.07 M

According to Protalix BioTherapeutics 's latest financial reports the company has C$61.07 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$59.1 M96.37%
2022-12-31C$30.09 M-39%
2021-12-31C$49.33 M0.38%
2020-12-31C$49.15 M113.11%
2019-12-31C$23.06 M-55.28%
2018-12-31C$51.57 M-19.82%
2017-12-31C$64.32 M-24.36%
2016-12-31C$85.04 M-19.82%
2015-12-31C$0.10 B66.97%
2014-12-31C$63.52 M-30.89%
2013-12-31C$91.91 M77.23%
2012-12-31C$51.86 M88.82%
2011-12-31C$27.46 M-23.57%
2010-12-31C$35.93 M-58.03%
2009-12-31C$85.61 M64.49%
2008-12-31C$52.04 M-14.12%
2007-12-31C$60.6 M126.76%
2006-12-31C$26.72 M384.2%
2005-12-31C$5.51 M796.91%
2004-12-31C$0.61 M-35.85%
2003-12-31C$0.95 M-24.79%
2002-12-31C$1.27 M-12.55%
2001-12-31C$1.45 M-39.45%
2000-12-31C$2.4 M13.69%
1999-12-31C$2.11 M6.88%
1998-12-31C$1.98 M153.24%
1997-12-31C$0.78 M-25.18%
1996-12-31C$1.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.35 B 477.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.40 B 2,207.18%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.63 B 15,669.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.06 B 4,914.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel